[
  {
    "ts": "2025-12-11T12:44:31+00:00",
    "headline": "Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update",
    "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that it had secured a five-year loan of $1.5 billion from Ares Management Corp (NYSE:ARES). The company made this announcement as it prepared to unveil strategy updates to analysts later that day. Moderna plans to […]",
    "url": "https://finance.yahoo.com/news/moderna-secures-1-5b-five-124431280.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "47fb9ff3-40f3-3e59-b6be-a90f504166e9",
      "content": {
        "id": "47fb9ff3-40f3-3e59-b6be-a90f504166e9",
        "contentType": "STORY",
        "title": "Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update",
        "description": "",
        "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that it had secured a five-year loan of $1.5 billion from Ares Management Corp (NYSE:ARES). The company made this announcement as it prepared to unveil strategy updates to analysts later that day. Moderna plans to […]",
        "pubDate": "2025-12-11T12:44:31Z",
        "displayTime": "2025-12-11T12:44:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Moderna Secures $1.5B Five-Year Loan from Ares Management Ahead of Strategy Update",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1_dbUZV6cAq6Zm3QVCmGdw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6tuqwu6weMIqVwqkD1gIVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/db8da8639da22058dd703222358d64b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-secures-1-5b-five-124431280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-secures-1-5b-five-124431280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "ARES"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T17:57:50+00:00",
    "headline": "Moderna (MRNA) Q3 2024 Earnings Call Transcript",
    "summary": "Stéphane Bancel: Thank you, Lavina.  In the third quarter of 2024 compared to the first quarter of 2023, we reduced operating expenses by $500 million across cost of sales, RD and SG&A. This figure excludes $1.4 billion of resizing charge in the first quarter of 2023.  Stéphane Bancel: This year, the COVID market benefited from U.S. regulatory approval that was 19 days earlier than in 2023.",
    "url": "https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q3-2024-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "2b23a248-f89e-3f18-a84b-e12cf808d5c7",
      "content": {
        "id": "2b23a248-f89e-3f18-a84b-e12cf808d5c7",
        "contentType": "STORY",
        "title": "Moderna (MRNA) Q3 2024 Earnings Call Transcript",
        "description": "",
        "summary": "Stéphane Bancel: Thank you, Lavina.  In the third quarter of 2024 compared to the first quarter of 2023, we reduced operating expenses by $500 million across cost of sales, RD and SG&A. This figure excludes $1.4 billion of resizing charge in the first quarter of 2023.  Stéphane Bancel: This year, the COVID market benefited from U.S. regulatory approval that was 19 days earlier than in 2023.",
        "pubDate": "2025-12-11T17:57:50Z",
        "displayTime": "2025-12-11T17:57:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q3-2024-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-q3-2024-earnings-175750483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T17:50:31+00:00",
    "headline": "Moderna signs deal worth up to $503m with Nanexa",
    "summary": "Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent dosing.",
    "url": "https://www.pharmaceutical-technology.com/news/moderna-signs-deal-worth-up-to-503m-with-nanexa/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "97f316f0-5efa-3303-8e82-53310853c23c",
      "content": {
        "id": "97f316f0-5efa-3303-8e82-53310853c23c",
        "contentType": "STORY",
        "title": "Moderna signs deal worth up to $503m with Nanexa",
        "description": "",
        "summary": "Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent dosing.",
        "pubDate": "2025-12-11T17:50:31Z",
        "displayTime": "2025-12-11T17:50:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/a2c421e204ed669b2b13f138fab78476",
          "originalWidth": 2560,
          "originalHeight": 1967,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DaF._Esay1ZIQhANXz6g9Q--~B/aD0xOTY3O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/pharmaceutical_technology_376/a2c421e204ed669b2b13f138fab78476.cf.webp",
              "width": 2560,
              "height": 1967,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TIvCIVUUxo2tTHlcsKHBCA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/a2c421e204ed669b2b13f138fab78476.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/moderna-signs-deal-worth-up-to-503m-with-nanexa/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-signs-deal-worth-503m-175031363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NANEXA.ST"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T17:44:50+00:00",
    "headline": "Moderna (MRNA) Q3 2025 Earnings Call Transcript",
    "summary": "Stéphane Bancel: In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, mRESVIA.  Stéphane Bancel: During the quarter, we made good progress across our 3 strategic priorities.  For Spikevax, our original COVID vaccine, we received approval in 40 countries for the seasonal 2025-2026 strain update.",
    "url": "https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q3-2025-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c1f199fd-061f-39d6-b011-0b10fea883e5",
      "content": {
        "id": "c1f199fd-061f-39d6-b011-0b10fea883e5",
        "contentType": "STORY",
        "title": "Moderna (MRNA) Q3 2025 Earnings Call Transcript",
        "description": "",
        "summary": "Stéphane Bancel: In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, mRESVIA.  Stéphane Bancel: During the quarter, we made good progress across our 3 strategic priorities.  For Spikevax, our original COVID vaccine, we received approval in 40 countries for the seasonal 2025-2026 strain update.",
        "pubDate": "2025-12-11T17:44:50Z",
        "displayTime": "2025-12-11T17:44:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q3-2025-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-q3-2025-earnings-174450483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T19:03:40+00:00",
    "headline": "Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.?",
    "summary": "Noubar Afeyan says American hesitation is creating a strategic opening China is moving fast to exploit.",
    "url": "https://finance.yahoo.com/news/moderna-sounds-alarm-china-seize-190340297.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "b2b14571-cfa1-35f9-a6f5-a54305e83ed6",
      "content": {
        "id": "b2b14571-cfa1-35f9-a6f5-a54305e83ed6",
        "contentType": "STORY",
        "title": "Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.?",
        "description": "",
        "summary": "Noubar Afeyan says American hesitation is creating a strategic opening China is moving fast to exploit.",
        "pubDate": "2025-12-11T19:03:40Z",
        "displayTime": "2025-12-11T19:03:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/affd672c7e3b6b05023e1a8ef798291a",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/edKKLjfF5qysqWEgzE6Gzg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/affd672c7e3b6b05023e1a8ef798291a.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0wvZ8t2uImk183ovELOTbQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/affd672c7e3b6b05023e1a8ef798291a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-sounds-alarm-china-seize-190340297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-sounds-alarm-china-seize-190340297.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]